241 related articles for article (PubMed ID: 21755523)
1. Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine.
Yıldırım S; Akar S; Kuyucu M; Yıldırım A; Dane S; Aygül R
Cell Biochem Funct; 2011 Oct; 29(7):549-54. PubMed ID: 21755523
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia.
Kim YJ; Park H; Lee HY; Ahn YM; Ha EH; Suh SH; Pang MG
Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):47-52. PubMed ID: 16949193
[TBL] [Abstract][Full Text] [Related]
3. A preliminary study of human paraoxonase and PON 1 L/M55-PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease.
Kaman D; Ilhan N; Metin K; Akbulut M; Ustündağ B
Cell Biochem Funct; 2009 Mar; 27(2):88-92. PubMed ID: 19226538
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase gene Q192R & L55M polymorphisms in Indians with acute myocardial infarction & association with oxidized low density lipoprotein.
Lakshmy R; Ahmad D; Abraham RA; Sharma M; Vemparala K; Das S; Reddy KS; Prabhakaran D
Indian J Med Res; 2010 Apr; 131():522-9. PubMed ID: 20424303
[TBL] [Abstract][Full Text] [Related]
5. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
Sampson MJ; Braschi S; Willis G; Astley SB
Clin Sci (Lond); 2005 Aug; 109(2):189-97. PubMed ID: 15853770
[TBL] [Abstract][Full Text] [Related]
7. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
[TBL] [Abstract][Full Text] [Related]
8. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
Agachan B; Yilmaz H; Karaali Z; Isbir T
Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
[TBL] [Abstract][Full Text] [Related]
12. Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women.
Kumru S; Aydin S; Gursu MF; Ozcan Z
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):177-81. PubMed ID: 15140512
[TBL] [Abstract][Full Text] [Related]
13. Effects of estrogen-only therapy on LDL oxidation in women with hysterectomy: does paraoxonase genotype play a role?
Akçay YD; Sagin FG; Sendağ F; Oztekin K; Sozmen EY
Maturitas; 2006 Feb; 53(3):325-32. PubMed ID: 16023312
[TBL] [Abstract][Full Text] [Related]
14. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
[TBL] [Abstract][Full Text] [Related]
15. Association of L55M and Q192R polymorphisms of paraoxonase-1 gene with preeclampsia.
Yaghmaei M; Hashemi M; Azarian A; Moazeni-Roodi A; Mokhtari M; Naghavai A; Salimi S; Mohammadi M; Taheri M; Ghavami S
Arch Med Res; 2011 May; 42(4):324-8. PubMed ID: 21820612
[TBL] [Abstract][Full Text] [Related]
16. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
Jiang XL; Li M; Zhou JG; Yang QB; Du LJ; Du J
Cell Biochem Biophys; 2011 Nov; 61(2):461-6. PubMed ID: 21748243
[TBL] [Abstract][Full Text] [Related]
17. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
18. Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet.
Schulpis KH; Bartzeliotou A; Tsakiris S; Gounaris A; Papassotiriou I
Eur J Clin Nutr; 2007 Jun; 61(6):803-8. PubMed ID: 17203019
[TBL] [Abstract][Full Text] [Related]
19. Maternal chronic hepatitis B virus is implicated with low neonatal paraoxonase/arylesterase activities.
Schulpis KH; Barzeliotou A; Papadakis M; Rodolakis A; Antsaklis A; Papassotiriou I; Vlachos GD
Clin Biochem; 2008 Mar; 41(4-5):282-7. PubMed ID: 18035058
[TBL] [Abstract][Full Text] [Related]
20. Serum paraoxonase levels in gastric cancer.
Akçay MN; Yilmaz I; Polat MF; Akçay G
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclxxiii-cclxxv. PubMed ID: 15244199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
